Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 364758, 10 pages
http://dx.doi.org/10.1155/2015/364758
Research Article

A Subgroup of Latently Mycobacterium tuberculosis Infected Individuals Is Characterized by Consistently Elevated IgA Responses to Several Mycobacterial Antigens

1DST/NRF Centre of Excellence for Biomedical TB Research and MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, P.O. Box 19063, Tygerberg 7505, South Africa
2Lionex Diagnostics and Therapeutics, Salzdahlumer Straße 196, 38126 Braunschweig, Germany

Received 21 May 2014; Revised 7 August 2014; Accepted 21 August 2014

Academic Editor: Kostas Spiropoulos

Copyright © 2015 Ralf Baumann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione, “Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project,” Journal of the American Medical Association, vol. 282, no. 7, pp. 677–686, 1999. View at Google Scholar
  2. Stop TB partnership, The global plan to stop TB (2011–2015), 2011.
  3. B. D. Robertson, D. Altmann, C. Barry et al., “Detection and treatment of subclinical tuberculosis,” Tuberculosis, vol. 92, no. 6, pp. 447–452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kunnath-Velayudhan, A. L. Davidow, H.-Y. Wang et al., “Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients,” The Journal of Infectious Diseases, vol. 206, no. 5, pp. 697–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. H. L. David, F. Papa, P. Cruaud et al., “Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis,” International Journal of Leprosy, vol. 60, no. 2, pp. 208–224, 1992. View at Google Scholar · View at Scopus
  6. E. D. Chan, R. Reves, J. T. Belisle, P. J. Brennan, and W. E. Hahn, “Diagnosis of tuberculosis by a visually detectable immunoassay for lipoarabinomannan,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1713–1719, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. K. K. Singh, X. Zhang, A. S. Patibandla, P. Chien, and S. Laal, “Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences,” Infection and Immunity, vol. 69, no. 6, pp. 4185–4191, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. K. K. Singh, Y. Dong, S. A. Patibandla, D. N. McMurray, V. K. Arora, and S. Laal, “Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) protein during incipient and clinical tuberculosis,” Infection and Immunity, vol. 73, no. 8, pp. 5004–5014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Ferreira, R. Soares, and M. Arala-Chaves, “Susceptibility to infection with Mycobacterium avium is paradoxically correlated with increased synthesis of specific anti-bacterial antibodies,” International Immunology, vol. 3, no. 5, pp. 445–452, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. K. R. Steingart, L. L. Flores, N. Dendukuri et al., “Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis,” PLoS Medicine, vol. 8, no. 8, Article ID e1001062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. T. Hoff, M. Abebe, P. Ravn et al., “Evaluation of Mycobacterium tuberculosis-specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark,” Clinical Infectious Diseases, vol. 45, no. 5, pp. 575–582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Diaz-Silvestre, P. Espinosa-Cueto, A. Sanchez-Gonzalez et al., “The 19-kDa antigen of Mycobacterium tuberculosis is a major adhesin that binds the mannose receptor of THP-1 monocytic cells and promotes phagocytosis of mycobacteria,” Microbial Pathogenesis, vol. 39, no. 3, pp. 97–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Arko-Mensah, E. Julián, M. Singh, and C. Fernández, “TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-γ-induced killing of mycobacteria by murine macrophages,” Scandinavian Journal of Immunology, vol. 65, no. 2, pp. 148–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Sánchez, P. Espinosa, T. García, and R. Mancilla, “The 19 kDa Mycobacterium tuberculosis lipoprotein (LpqH) induces macrophage apoptosis through extrinsic and intrinsic pathways: a role for the mitochondrial apoptosis-inducing factor,” Clinical and Developmental Immunology, vol. 2012, Article ID 950503, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. F. F. Kao, S. Mahmuda, R. Pinto, J. A. Triccas, N. P. West, and W. J. Britton, “The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice,” PLoS ONE, vol. 7, no. 5, Article ID e34991, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Baumann, S. Kaempfer, N. N. Chegou et al., “Serodiagnostic markers for the prediction of the outcome of intensive phase tuberculosis therapy,” Tuberculosis, vol. 93, no. 2, pp. 239–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Palma, R. Spallek, G. Piccaro et al., “The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection,” Clinical and Developmental Immunology, vol. 2011, Article ID 690328, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Abebe, C. Holm-Hansen, H. G. Wiker, and G. Bjune, “Progress in serodiagnosis of Mycobacterium tuberculosis infection,” Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 176–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Kunnath-Velayudhan, H. Salamon, H.-Y. Wang et al., “Dynamic antibody responses to the Mycobacterium tuberculosis proteome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14703–14708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Schnell, D. Ågren, and G. Schneider, “1.9 Å structure of the signal receiver domain of the putative response regulator NarL from Mycobacterium tuberculosis,” Acta Crystallographica F: Structural Biology and Crystallization Communications, vol. 64, pp. 1096–1100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. A. de Souza, N. A. Leversen, H. Målen, and H. G. Wiker, “Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway,” Journal of Proteomics, vol. 75, no. 2, pp. 502–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Azzurri, G. V. Kanaujia, O. Y. Sow et al., “Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea,” International Journal of Immunopathology and Pharmacology, vol. 19, no. 1, pp. 199–208, 2006. View at Google Scholar · View at Scopus
  23. J. Mattow, P. R. Jungblut, U. E. Schaible et al., “Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains,” Electrophoresis, vol. 22, pp. 2936–2946, 2001. View at Google Scholar
  24. M. Legesse, G. Ameni, G. Medhin et al., “IgA response to ESAT-6/CFP-10 and Rv2031 antigens varies in patients with culture-confirmed pulmonary tuberculosis, healthy mycobacterium tuberculosis-infected and non-infected individuals in a tuberculosis endemic setting, Ethiopia,” Scandinavian Journal of Immunology, vol. 78, no. 3, pp. 266–274, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. B. Conde, P. Suffys, J. R. Lapa E Silva, A. L. Kritski, and S. E. Dorman, “Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 1, pp. 94–97, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. O. Elson, J. A. Heck, and W. Stober, “T-cell regulation of murine IgA synthesis,” Journal of Experimental Medicine, vol. 149, no. 3, pp. 632–643, 1979. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Alvarez, O. Otero, F. Camacho et al., “Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection,” BMC immunology, vol. 14, supplement 1, article S3, 2013. View at Google Scholar · View at Scopus
  28. S. den Boon, S. W. P. van Lill, M. W. Borgdorff et al., “Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area,” Thorax, vol. 60, no. 7, pp. 555–557, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. E. M. Fine, J. Bruce, J. M. Ponnighaus, P. Nkhosa, A. Harawa, and E. Vynnycky, “Tuberculin sensitivity: conversions and reversions in a rural African population,” International Journal of Tuberculosis and Lung Disease, vol. 3, no. 11, pp. 962–975, 1999. View at Google Scholar · View at Scopus
  30. “Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society,” MMWR—Recommendations and Reports, vol. 49, pp. 1–51, 2000.
  31. G. Ferrara, M. Losi, R. D'Amico et al., “Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study,” The Lancet, vol. 367, no. 9519, pp. 1328–1334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Vassilopoulos, S. Tsikrika, C. Hatzara et al., “Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy,” Clinical and Vaccine Immunology, vol. 18, no. 12, pp. 2102–2108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Roberts, N. Beyers, A. Aguirre, and G. Walzl, “Immunosuppression during active tuberculosis is characterized by decreased interferon-γ production and CD25 expression with elevated forkhead box P3, transforming growth factor-β, and interleukin-4 mRNA levels,” Journal of Infectious Diseases, vol. 195, no. 6, pp. 870–878, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. G. F. Black, B. A. Thiel, M. O. Ota et al., “Immunogenicity of novel DosR regulon-encoded candidate antigens of mycobacterium tuberculosis in three high-burden populations in Africa,” Clinical and Vaccine Immunology, vol. 16, no. 8, pp. 1203–1212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Hutter and M. Singh, “Properties of the 40 kDa antigen of Mycobacterium tuberculosis, a functional L-alanine dehydrogenase,” Biochemical Journal, vol. 343, part 3, pp. 669–672, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Laal, K. M. Samanich, M. G. Sonnenberg, S. Zolla-Pazner, J. M. Phadtare, and J. T. Belisle, “Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens,” Clinical and Diagnostic Laboratory Immunology, vol. 4, no. 1, pp. 49–56, 1997. View at Google Scholar · View at Scopus
  37. I. Rosenkrands, C. Aagaard, K. Weldingh et al., “Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis,” Tuberculosis, vol. 88, no. 4, pp. 335–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Kitada, R. Maekura, N. Toyoshima et al., “Use of glycopeptidolipid core antigen for serodiagnosis of Mycobacterium avium complex pulmonary disease in immunocompetent patients,” Clinical and Diagnostic Laboratory Immunology, vol. 12, no. 1, pp. 44–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. S. Imaz and E. Zerbini, “Antibody response to culture filtrate antigens of Mycobacterium tuberculosis during and after treatment of tuberculosis patients,” The International Journal of Tuberculosis and Lung Disease, vol. 4, no. 6, pp. 562–569, 2000. View at Google Scholar · View at Scopus
  40. V. M. C. Silva, G. Kanaujia, M. L. Gennaro, and D. Menzies, “Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 5, pp. 478–484, 2003. View at Google Scholar · View at Scopus
  41. A. Davidow, G. V. Kanaujia, L. Shi et al., “Antibody profiles characteristic of Mycobacterium tuberculosis infection state,” Infection and Immunity, vol. 73, no. 10, pp. 6846–6851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. J. M. Achkar, Y. Dong, R. S. Holzman et al., “Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis,” Clinical and Vaccine Immunology, vol. 13, no. 11, pp. 1291–1293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Klopper, R. M. Warren, C. Hayes et al., “Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa,” Emerging Infectious Diseases, vol. 19, no. 3, pp. 449–455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. X. Rangaka, K. A. Wilkinson, J. R. Glynn et al., “Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 12, no. 1, pp. 45–55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. T. M. Doherty, A. Demissie, J. Olobo et al., “Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients,” Journal of Clinical Microbiology, vol. 40, no. 2, pp. 704–706, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Machingaidze, S. Verver, H. Mulenga et al., “Predictive value of recent quantiFERON conversion for tuberculosis disease in adolescents,” The American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 10, pp. 1051–1056, 2012. View at Publisher · View at Google Scholar · View at Scopus